171 related articles for article (PubMed ID: 38787429)
81. MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study.
Ma J; Chen K; Li S; Zhu L; Yu Y; Li J; Ma J; Ouyang J; Wu Z; Tan Y; He Z; Liu H; Pan Z; Li H; Liu Q; Song E
Eur Radiol; 2024 Mar; 34(3):1774-1789. PubMed ID: 37658888
[TBL] [Abstract][Full Text] [Related]
82. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy.
Chen S; Tang Y; Li N; Jiang J; Jiang L; Chen B; Fang H; Qi S; Hao J; Lu N; Wang S; Song Y; Liu Y; Li Y; Jin J
Front Oncol; 2021; 11():784156. PubMed ID: 34869040
[TBL] [Abstract][Full Text] [Related]
83. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
[TBL] [Abstract][Full Text] [Related]
84. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
[TBL] [Abstract][Full Text] [Related]
85. Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment.
Park NJ; Jeong JY; Park JY; Kim HJ; Park CS; Lee J; Park HY; Jung JH; Kim WW; Chae YS; Lee SJ; Kim WH
Sci Rep; 2021 Jun; 11(1):12992. PubMed ID: 34155253
[TBL] [Abstract][Full Text] [Related]
86. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
87. MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features.
Zheng H; Li J; Liu H; Ting G; Yin Q; Li R; Liu M; Zhang Y; Duan S; Li Y; Wang D
J Magn Reson Imaging; 2023 Jul; 58(1):236-246. PubMed ID: 36412264
[TBL] [Abstract][Full Text] [Related]
88. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
89. Development and external validation of MRI-based RAS mutation status prediction model for liver metastases of colorectal cancer.
Han Z; Tong Y; Zhu X; Sun D; Jia N; Feng Y; Yan K; Wei Y; He J; Ju H
J Surg Oncol; 2024 Mar; 129(3):556-567. PubMed ID: 37974474
[TBL] [Abstract][Full Text] [Related]
90. Prediction of recurrence risk factors in patients with early-stage cervical cancers by nomogram based on MRI handcrafted radiomics features and deep learning features: a dual-center study.
Zhang Y; Wu C; Du J; Xiao Z; Lv F; Liu Y
Abdom Radiol (NY); 2024 Jan; 49(1):258-270. PubMed ID: 37987856
[TBL] [Abstract][Full Text] [Related]
91. MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study.
Xu Z; Ding Y; Zhao K; Han C; Shi Z; Cui Y; Liu C; Lin H; Pan X; Li P; Chen M; Wang H; Deng X; Liang C; Xie Y; Liu Z
Eur Radiol; 2022 Dec; 32(12):8213-8225. PubMed ID: 35704112
[TBL] [Abstract][Full Text] [Related]
92. Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study.
Du Y; Cai M; Zha H; Chen B; Gu J; Zhang M; Liu W; Liu X; Liu X; Zong M; Li C
Eur Radiol; 2024 Jan; 34(1):136-148. PubMed ID: 37518678
[TBL] [Abstract][Full Text] [Related]
93. Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors.
Han S; Kim JH; Yoo J; Jang S
Eur Radiol; 2022 Apr; 32(4):2506-2517. PubMed ID: 34647178
[TBL] [Abstract][Full Text] [Related]
94. Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.
Zhang Y; Fan X; Song B; Liu Y; Chen Y; Zheng T; Guo Y; Duan T; Huang Z; Yang L
Eur Radiol; 2024 Feb; 34(2):1268-1279. PubMed ID: 37581659
[TBL] [Abstract][Full Text] [Related]
95. A deep-learning-based clinical risk stratification for overall survival in adolescent and young adult women with breast cancer.
Luo J; Diao B; Wang J; Yin K; Guo S; Hong C; Guo Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10423-10433. PubMed ID: 37277578
[TBL] [Abstract][Full Text] [Related]
96. Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology.
Wang K; Guo B; Yao Z; Li G
World J Surg Oncol; 2024 Jun; 22(1):145. PubMed ID: 38822338
[TBL] [Abstract][Full Text] [Related]
97. Effects of Preoperative Breast MRI on Breast Cancer Survival Outcomes in Women Aged 35 Years and Younger.
Park AR; Chae EY; Kim HJ; Cha JH; Shin HJ; Choi WJ; Kim HH
Radiology; 2023 May; 307(4):e221797. PubMed ID: 36975814
[TBL] [Abstract][Full Text] [Related]
98. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
99. Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
Choi JS; Ko ES; Ko EY; Han BK; Nam SJ
Medicine (Baltimore); 2016 Mar; 95(9):e3000. PubMed ID: 26945421
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
